메뉴 건너뛰기




Volumn 5, Issue 3, 2005, Pages 241-248

Development of COX-2 selective inhibitors - Therapeutic perspectives

Author keywords

COX 1; COX 2 inhibitors; COXIBs; Cyclooxygenase; Etoricoxib; NSAIDs; Prostaglandins; Vioxx

Indexed keywords

5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ABT 963; ACETYLSALICYLIC ACID; CELECOXIB; CIMICOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETODOLAC; ETORICOXIB; FURANONE DERIVATIVE; IBUPROFEN; IMIDAZOLE DERIVATIVE; IMRECOXIB; LUMIRACOXIB; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZOLONE; PARECOXIB; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRROLE DERIVATIVE; ROFECOXIB; UNCLASSIFIED DRUG; VALDECOXIB;

EID: 21344473038     PISSN: 15680134     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568013054022445     Document Type: Review
Times cited : (6)

References (122)
  • 5
    • 21344452016 scopus 로고    scopus 로고
    • Washington post. September 30
    • Barbsh, F. Washington post. 2004, September 30.
    • (2004)
    • Barbsh, F.1
  • 6
    • 5044233737 scopus 로고    scopus 로고
    • Editorial - Vioxx
    • Editorial - Vioxx, Lancet, 2004, 364, 1287.
    • (2004) Lancet , vol.364 , pp. 1287
  • 9
    • 21344465352 scopus 로고    scopus 로고
    • News article
    • Xavier, Bosch. News article. Lancet, 2004, 363, 298.
    • (2004) Lancet , vol.363 , pp. 298
    • Xavier, B.1
  • 89
    • 21344442091 scopus 로고    scopus 로고
    • Scrip, 2004, 3001, 23.
    • (2004) Scrip , vol.3001 , pp. 23
  • 120
    • 21344464148 scopus 로고    scopus 로고
    • Scrip, 2004, 3010, 20.
    • (2004) Scrip , vol.3010 , pp. 20


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.